RETRACTED: Enhancement of Proliferation and Invasion of Gastric Cancer Cell by KDM5C Via Decrease in p53 Expression
Open Access
- 7 February 2016
- journal article
- retracted article
- Published by SAGE Publications in Technology in Cancer Research & Treatment
- Vol. 16 (2), 141-149
- https://doi.org/10.1177/1533034616629261
Abstract
Gastric cancer is a malignancy with high incidence and the second leading cause of cancer death worldwide. Development of efficient therapies against gastric cancer is urgent. Until now, the mechanisms of gastric cancer genesis remain elusive. The KDM5C is a histone demethylase that promotes cancer cell growth and is enriched in drug-resistant cancer cells. But the pathogenic breadth and mechanistic aspects of this effect relative to gastric cancer have not been defined. In present study, we found that KDM5C was overexpressed in gastric cancer cell lines and gastric cancer tissues but not in normal gastric tissues. The proliferation and invasive potential of gastric cancer cells was significantly increased by ectopic expression of KDM5C. Contrarily, RNA interference targeting KDM5C in gastric cancer cells significantly decreased the proliferation and invasive potential of cells. Moreover, we also found that the expression of p53 was modulated by KDM5C. Cells with overexpression of KDM5C exhibited greatly decreased p53 expression, whereas silencing of KDM5C expression dramatically increased p53 expression at both the messenger RNA and protein levels. Inhibition of p53 by small-interfering RNA reversed the shKDM5C-induced proliferation and invasion. Our results collectively suggested that KDM5C played a role in gastric cancer cells proliferation and invasion, which may be partly associated with the p53 expression.Keywords
This publication has 26 references indexed in Scilit:
- Jumonji domain-containing protein 2B silencing induces DNA damage response via STAT3 pathway in colorectal cancerBritish Journal of Cancer, 2014
- Stimulation of β-catenin and colon cancer cell growth by the KDM4B histone demethylaseInternational Journal of Oncology, 2014
- The oncogenic potential of Jumonji D2 (JMJD2/KDM4) histone demethylase overexpressionBiochemistry and Cell Biology, 2013
- KDM4/JMJD2 Histone Demethylases: Epigenetic Regulators in Cancer CellsCancer Research, 2013
- Transient JMJD2B-Mediated Reduction of H3K9me3 Levels Improves Reprogramming of Embryonic Stem Cells into Cloned EmbryosMolecular and Cellular Biology, 2013
- The lysine demethylase, KDM4B, is a key molecule in androgen receptor signalling and turnoverNucleic Acids Research, 2013
- HIF-1α-induced histone demethylase JMJD2B contributes to the malignant phenotype of colorectal cancer cells via an epigenetic mechanismCarcinogenesis: Integrative Cancer Research, 2012
- Recent advances in non-small cell lung cancer biology and clinical management.2012
- The Histone Demethylase JMJD2B Plays an Essential Role in Human Carcinogenesis through Positive Regulation of Cyclin-Dependent Kinase 6Cancer Prevention Research, 2011
- The Histone Demethylase JMJD2B Is Regulated by Estrogen Receptor α and Hypoxia, and Is a Key Mediator of Estrogen Induced GrowthCancer Research, 2010